10 research outputs found

    SELENE: Self-Monitored Dependable Platform for High-Performance Safety-Critical Systems.

    Get PDF
    © 2020 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.[Otros] xisting HW/SW platforms for safety-critical systems suffer from limited performance and/or from lack of flexibility due to building on specific proprietary components. This jeopardizes their wide deployment across domains. While some research has been done to overcome these limitations, they have had limited success owing to missing flexibility and extensibility. Flexibility and extensibility are the cornerstones of industry adoption: industries dealing in capital goods need technologies on which they can rely on during decades (e.g. avionics, space, automotive). SELENE aims at covering this gap by proposing a new family of safety-critical computing platforms, which builds upon open source components such as the RISC-V instruction set architecture, GNU/Linux, and the Jailhouse hypervisor. SELENE will develop an advanced computing platform that is able to: (1) adapt the system to the specific requirements of different application domains, to changing environmental conditions, and to internal conditions of the system itself; (2) allow the integration of applications of different criticalities and performance demands in the same platform, guaranteeing functional and temporal isolation properties; (3) achieve flexible diverse redundancy by exploiting the inherent redundant capabilities of the multicore; and (4) efficiently execute compute-intensive applications by means of specific accelerators.This work has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement no. 871467.Hernández Luz, C.; Flich Cardo, J.; Paredes Palacios, R.; Lefebvre, C.; Allende, I.; Abella, J.; Trilla, D.... (2020). SELENE: Self-Monitored Dependable Platform for High-Performance Safety-Critical Systems. IEEE. 370-377. https://doi.org/10.1109/DSD51259.2020.00066S37037

    Interferon-Îł Activates Nuclear Factor-Îş B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response

    Get PDF
    Our previous studies have demonstrated that the effects of the immune cytokine interferon-Îł (IFN-Îł) in immune-mediated demyelinating diseases are mediated, at least in part, by the unfolded protein response (UPR) in oligodendrocytes. Data indicate that some biological effects of IFN-Îł are elicited through activation of the transcription factor nuclear factor-ÎşB (NF-ÎşB). Interestingly, it has been shown that activation of the pancreatic endoplasmic reticulum kinase (PERK) branch of the UPR triggers NF-ÎşB activation. In this study, we showed that IFN-Îł-induced NF-ÎşB activation was associated with activation of PERK signaling in the oligodendroglial cell line Oli-neu. We further demonstrated that blockage of PERK signaling diminished IFN-Îł-induced NF-ÎşB activation in Oli-neu cells. Importantly, we showed that NF-ÎşB activation in oligodendrocytes correlated with activation of PERK signaling in transgenic mice that ectopically express IFN-Îł in the central nervous system (CNS), and that enhancing IFN-Îł-induced activation of PERK signaling further increased NF-ÎşB activation in oligodendrocytes. Additionally, we showed that suppression of the NF-ÎşB pathway rendered Oli-neu cells susceptible to the cytotoxicity of IFN-Îł, reactive oxygen species, and reactive nitrogen species. Our results indicate that the UPR is involved in IFN-Îł-induced NF-ÎşB activation in oligodendrocytes and suggest that NF-ÎşB activation by IFN-Îł represents one mechanism by which IFN-Îł exerts its effects on oligodendrocytes in immune-mediated demyelinating diseases

    NF-ÎşB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications

    No full text
    corecore